跳至主要内容
临床试验/NCT03602742
NCT03602742Unknown不适用

Comparison of 24-hour Holter Monitoring Versus 14-day Continuous ECG Patch Monitoring EZYPRO

Sigknow Biomedical Co., Ltd.2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2018年3月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
150
试验地点
2
主要终点
Compare the detection difference of any type of arrhythmia between 14-day continuous ECG patch and 24-hour Holter monitor device among patients with suspected cardiac arrhythmia events over total wearing time

研究概览

简要总结

This is an open-label study to investigate the functional features of prolonged monitoring by 14-day EZYPRO® to improve the medical care and/or diagnosis for the patient with arrhythmia. Patients will be enrolled by outpatient basis from two clinical study sites. Enrolled patients will wear a traditional 24-hour Holter monitor and an 14-day EZYPRO® which can provide monitoring data for up to 14 days. This study will allow a direct comparison between two devices.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provision of signed written informed consent before enrollment into the study
  • Are able to communicate with the investigators
  • With suspected arrhythmia related signs and symptoms, judged by the investigators
  • Patients intend to wear ECG moniotrs
  • Males and females, 20 years of age or older

排除标准

  • Patients with skin allergies or injury, judged by investigators
  • Patients with specific arrhythmia or specific treatments, interfere with study evaluations, judged by investigators
  • Pregnant women
  • Currently participating in another trial or who participated in a previous clinical trial

研究组 & 干预措施

24-hour Holter and 14-day EZYPRO®

Other

This is an open-label study to investigate the functional features of prolonged monitoring by 14-day EZYPRO® to improve the medical care and/or diagnosis for the patient with arrhythmia. One arm included.

干预措施: EZYPRO® (Device)

结局指标

主要结局

Compare the detection difference of any type of arrhythmia between 14-day continuous ECG patch and 24-hour Holter monitor device among patients with suspected cardiac arrhythmia events over total wearing time

时间窗: Up to14 days

The arrhythmia events of 14-day continuous ECG patch monitor (investigational device) and 24-hour Holter monitor will be analyzed by the qualified ECG technicians and determined by physician investigators at the study sites. Arrhythmia events are defined as detection of any 1 of 6 arrhythmias, including: * Supraventricular tachycardia (\>4 beats, not including atrial fibrillation or flutter) * Atrial fibrillation/flutter (\>4 beats) * Pause \>3 seconds * Atrioventricular block (Second-degree, 2:1 or third-degree atrioventricular block, need an advanced determination by the investigators) * Ventricular tachycardia (\>4 beats) * Polymorphic ventricular tachycardia/ventricular fibrillation In the end, all the detection will be confirmed by the investigators. McNemar's tests will be used to compare the matched pairs of proportion data.

次要结局

  • The wearing time of 14-day continuous ECG patch (Study Compliance)(Up to14 days)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验